Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-10-09
DOI
10.3389/fphar.2018.01097
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design, synthesis and anticancer studies of novel aminobenzazolyl pyrimidines as tyrosine kinase inhibitors
- (2018) Rupesh Chikhale et al. BIOORGANIC CHEMISTRY
- Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters
- (2018) Ying-Fang Fan et al. CANCER LETTERS
- Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors
- (2018) Mahaveer Singh et al. DRUG DISCOVERY TODAY
- Recent advances in the discovery of small molecule c-Met Kinase inhibitors
- (2018) Palak K. Parikh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis
- (2018) Lina Tang et al. OncoTargets and Therapy
- Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
- (2017) Giovanni Luca Beretta et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 2-Trifluoromethyl-2-Hydroxypropionamide Derivatives as Novel Reversal Agents of ABCG2 (BCRP)-Mediated Multidrug Resistance: Synthesis and Biological Evaluations
- (2017) Rishil J. Kathawala et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Structure of the human multidrug transporter ABCG2
- (2017) Nicholas M. I. Taylor et al. NATURE
- Receptor tyrosine kinase expression and phosphorylation in canine nasal carcinoma
- (2017) Samuel E. Hocker et al. RESEARCH IN VETERINARY SCIENCE
- Targeting receptor tyrosine kinase EphB4 in cancer therapy
- (2017) Yinnan Chen et al. SEMINARS IN CANCER BIOLOGY
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- ABC transporters as mediators of drug resistance and contributors to cancer cell biology
- (2016) Jamie I. Fletcher et al. DRUG RESISTANCE UPDATES
- Olmutinib: First Global Approval
- (2016) Esther S. Kim DRUGS
- Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells
- (2016) Xiao-Yu Zhang et al. MOLECULES
- Mechanisms of drug resistance in colon cancer and its therapeutic strategies
- (2016) Tao Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters
- (2016) Yun-Kai Zhang et al. Scientific Reports
- Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients
- (2015) Xueqin Chen et al. Cancer Cell International
- Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance
- (2015) W. Miklos et al. CANCER LETTERS
- Variability in bioavailability of small molecular tyrosine kinase inhibitors
- (2015) Maikel Herbrink et al. CANCER TREATMENT REVIEWS
- Molecular mechanisms of drug resistance and its reversal in cancer
- (2015) Melis Kartal-Yandim et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Semi-synthetic ocotillol analogues as selective ABCB1-mediated drug resistance reversal agents
- (2015) Yun-Kai Zhang et al. Oncotarget
- Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
- (2014) Qiong Wu et al. CANCER LETTERS
- Unknown
- (2014) Shao-lin Ma et al. MOLECULAR MEDICINE
- Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
- (2014) Nagaraju Anreddy et al. MOLECULES
- Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters
- (2013) J. Jacob Strouse et al. ANALYTICAL BIOCHEMISTRY
- Different strategies to overcome multidrug resistance in cancer
- (2013) Manju Saraswathy et al. BIOTECHNOLOGY ADVANCES
- Acidic extracellular microenvironment and cancer
- (2013) Yasumasa Kato et al. Cancer Cell International
- Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy
- (2012) Dariusz Pytel et al. Anti-Cancer Agents in Medicinal Chemistry
- Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
- (2012) Suneet Shukla et al. DRUG RESISTANCE UPDATES
- Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome
- (2010) Motofumi Tanaka et al. CANCER
- Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)
- (2010) Zhanglin Ni et al. CURRENT DRUG METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started